Leukocyte Proteinase-3 (Wegener's autoantigen)
CAT No: ta-549
Synonyms/Alias:Leukocyte Proteinase-3 (Wegener's autoantigen) (169-177)
Leukocyte Proteinase-3(169-177) is a synthetic peptide fragment corresponding to amino acids 169 through 177 of human proteinase 3, a serine protease predominantly expressed in neutrophil granulocytes. As a defined peptide sequence derived from a functionally significant region of the parent protein, it serves as a valuable tool for dissecting the structural and biological properties of proteinase 3 in immunological and inflammatory processes. The 169-177 segment is of particular interest due to its involvement in epitope formation, protein-protein interactions, and its potential role in modulating immune recognition. Researchers utilize this peptide in a variety of experimental contexts to elucidate the mechanistic underpinnings of neutrophil-mediated responses and to advance understanding of serine protease function in innate immunity.
Epitope mapping: Synthetic peptides representing discrete regions of proteinase 3, such as the 169-177 fragment, are widely employed in epitope mapping studies. By enabling precise identification of linear B-cell or T-cell epitopes, the peptide facilitates the characterization of immune recognition sites within the parent protein. This approach is critical for unraveling the molecular basis of autoimmune responses, particularly in conditions where proteinase 3 serves as a target antigen. The use of defined peptide segments allows for systematic screening of antibody or T-cell reactivity, thereby supporting the development of more refined immunological assays and research models.
Autoantibody research: The 169-177 peptide fragment is instrumental in studies investigating the specificity and binding characteristics of anti-neutrophil cytoplasmic antibodies (ANCAs), especially those directed against proteinase 3. By serving as a substrate in immunoassays, it enables detailed analysis of autoantibody-epitope interactions. This is particularly relevant for understanding autoimmune vasculitides, where proteinase 3 is a major antigenic target. The peptide's defined sequence allows for controlled assessment of antibody recognition, contributing to the refinement of serological assays and the elucidation of disease mechanisms.
T-cell activation assays: In cellular immunology, the peptide is used to probe T-cell responses to proteinase 3-derived epitopes. Its application in antigen presentation studies allows researchers to examine the activation, proliferation, and cytokine secretion profiles of T-cell populations exposed to specific peptide sequences. This is essential for dissecting antigen-specific T-cell immunity and for modeling the cellular pathways involved in immune-mediated inflammation. The defined nature of the 169-177 peptide ensures reproducibility and specificity in functional assays.
Peptide binding studies: The defined sequence of this peptide makes it a valuable probe for analyzing peptide-MHC binding affinities and for studying the structural determinants of antigen presentation. By incorporating the fragment into binding assays, researchers can assess the interaction of proteinase 3-derived epitopes with various MHC class I or II molecules. These studies inform the design of peptide-based immunological tools and contribute to a deeper understanding of peptide processing and presentation in the context of immune surveillance.
Peptide synthesis and method development: As a short, well-characterized peptide, the 169-177 fragment is frequently used in the optimization and validation of synthetic peptide production techniques. Its sequence serves as a model substrate for evaluating coupling efficiencies, purification strategies, and analytical methodologies in peptide chemistry. This utility extends to the development of quantitative assays and the benchmarking of peptide-based analytical workflows, supporting both research and industrial applications in the field of synthetic peptide technology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.